Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-442 (Letaxaban) in Acute Coronary Syndromes
NCT00677053Phase 2Completed
- Sponsor
- Takeda
- Start
- Mar 2008
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands
- Countries
- 19
01
Overview
A Phase 2 trial of letaxaban in acute coronary syndrome (ACS), sponsored by Takeda. Started Mar 2008; status: completed.
02
Drugs
letaxaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00677053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677053.